MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202637036184 A) filed by Hanmi Pharmaceutical Co. , Ltd. on March 25, 2026, for Novel Phthalazine Derivative Compound As Sos1 Inhibitor, And Use Thereof.
Inventors include Kong, Tae Yeon; Park, Won Gi; Byun, Joo Yun; Jung, Seung Hyun; Choi, Jae Yul; Kim, Min Jeong; and Ahn, Young Gil.
The application for the patent was published on August 07, 2026, under issue no. 32/2026.
Abstract: The present invention relates to a novel phthalazine derivative compound as an SOS1 inhibitor, and a use thereof, and more specifically to: a novel phthalazine derivative compound having inhibitory activity against SOS1 binding to RAS family proteins and/or RAC1; a pharmacologically acceptable salt thereof; or a pharmaceutical composition containing the compound.
Disclaimer: Curated by HT Syndication.
